Lotus Eye Hospital and Institute Limited (LOTUSEYE) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Lotus Eye Hospital and Institute Limited stock ₹80.10, price ₹101, that is 20.8% below the price, quality 48 out of 100. Rating: overvalued. Calculated from audited financials with 12 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Lotus Eye Hospital and Institute Limited
LOTUSEYE · NSEExpensive (fair value 21% below the price) and price moving sideways, but company just good enough: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range ₹39.62 – ₹141.38 · fair‑value band ₹60.31 – ₹99.89 · the ₹101.19 price screens above the ₹80.10 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Lotus Eye Hospital and Institute is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India.
Show moreShow less
The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments.
It provides treatment services for various eye problems, such as refractive, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and cornea infections, as well as various eye related courses.
The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.
Stock analysis
Lotus Eye Hospital and Institute Limited (LOTUSEYE) currently trades at ₹101.19, while our model-based Fair Value estimate is ₹80.10, 21% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹71.62 per share, and 4 of the 12 models we run sit above the ₹101.19 price.
Bear case: the Earnings-Based group reads lowest at ₹31.10, and 8 of the 12 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹60.31 (bear) to ₹99.89 (bull), the price of ₹101.19 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 48/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Lotus Eye Hospital and Institute Limited reported revenue of ₹537M in FY2026 versus ₹389M in FY2022, a compound +8.4%/yr. Reported net income was ₹804K in FY2026, compounding −59.5%/yr from FY2022.
Key figures
Market cap ₹2.1B (≈ $22.2M) Micro · P/S ratio 3.98 · EPS (TTM) ₹0.0800 · Net margin 0.3% · Return on equity 0.1% · Return on assets (EBIT) 5.7% (5-year average) · Operating margin 7.7% · Revenue (TTM) ₹573M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 20 out of 100 (low confidence).
What moves the price
The share trades about 28% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −2% fair-value upside, at −21%, LOTUSEYE screens richer than that median.
Fair Value models
All 12 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
LOTUSEYE screens overvalued: fair value 21% below the price. Compare with HCA Healthcare, Inc →
Compare Lotus Eye Hospital and Institute Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 249 stocks
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- PEG ratio by industry
- Revenue growth by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Fresenius Medical Care AG FMS | $22.03 | $45.73 | +108% | vs LOTUSEYE |
| DaVita Inc DVA | $174.56 | $218.90 | +25% | vs LOTUSEYE |
| Aier Eye Hospital Group 300015 | ¥8.99 | ¥10.88 | +21% | vs LOTUSEYE |
| HCA Healthcare, Inc HCA | $499.05 | $547.34 | +10% | vs LOTUSEYE |
| Tenet Healthcare Corporation THC | $286.03 | $279.20 | −2% | vs LOTUSEYE |
| The Ensign Group ENSG | $188.41 | $140.09 | −26% | vs LOTUSEYE |
| Encompass Health Corporation EHC | $140.99 | $94.81 | −33% | vs LOTUSEYE |
| Fresenius SE FRE | €53.86 | €34.77 | −35% | vs LOTUSEYE |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,771 | ₹5,234 | −40% | vs LOTUSEYE |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 211.40 SAR | 109.45 SAR | −48% | vs LOTUSEYE |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Lotus Eye Hospital and Institute Limited (LOTUSEYE) overvalued or undervalued?
What is the fair value of LOTUSEYE?
What is the quality score of LOTUSEYE?
What is the price target for Lotus Eye Hospital and Institute Limited (LOTUSEYE)?
What is the Lotus Eye Hospital and Institute Limited stock forecast for 2026?
What is the revenue of Lotus Eye Hospital and Institute Limited (LOTUSEYE)?
What is the intrinsic value of Lotus Eye Hospital and Institute Limited (LOTUSEYE)?
Is Lotus Eye Hospital and Institute Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of LOTUSEYE?
How much is Lotus Eye Hospital and Institute Limited worth?
What do the bullish and bearish scenarios say about LOTUSEYE?
How solid is the balance sheet of Lotus Eye Hospital and Institute Limited (LOTUSEYE)?
How far is LOTUSEYE from its 52-week high?
Which stocks are comparable to Lotus Eye Hospital and Institute Limited?
Is Lotus Eye Hospital and Institute Limited stock attractive at the current price?
How is the fair value of LOTUSEYE calculated?
Is it still worth investing in stocks now?
What is the share price of Lotus Eye Hospital and Institute Limited (LOTUSEYE)?
What should I pay attention to with Lotus Eye Hospital and Institute Limited right now?
Key figures of Lotus Eye Hospital and Institute Limited
How large is the market capitalisation of Lotus Eye Hospital and Institute Limited (LOTUSEYE)?
What is the P/S ratio of Lotus Eye Hospital and Institute Limited (LOTUSEYE)?
What are the earnings per share of Lotus Eye Hospital and Institute Limited (LOTUSEYE)?
What is the net margin of Lotus Eye Hospital and Institute Limited (LOTUSEYE)?
What is the return on equity of Lotus Eye Hospital and Institute Limited (LOTUSEYE)?
What is the EBIT return on assets of Lotus Eye Hospital and Institute Limited (LOTUSEYE)?
What is the operating margin of Lotus Eye Hospital and Institute Limited (LOTUSEYE)?
How fast is revenue growing at Lotus Eye Hospital and Institute Limited (LOTUSEYE)?
How fast are earnings growing at Lotus Eye Hospital and Institute Limited (LOTUSEYE)?
How much free cash flow does Lotus Eye Hospital and Institute Limited (LOTUSEYE) generate?
How much net debt does Lotus Eye Hospital and Institute Limited (LOTUSEYE) carry?
Watch Lotus Eye Hospital and Institute Limited in the live analysis
One click puts Lotus Eye Hospital and Institute Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.